From MLB’s media relations department to my inbox to your eyes: MLB and the MLBPA released the annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator. It’s the thing that says how many positive drug tests there were, for what, etc.
The notable numbers, which cover the period starting when the 2011 World Series ended until the 2012 World Series ended:
- The total number of drug tests: 5136. Of these, 3,955 were urine tests and 1,181 were blood tests;
- There were eighteen positives that resulted in discipline. Seven were for PEDs, 11 were for stimulants;
- There were 119 Therapeutic Use Exemptions granted. Of these, 116 were for ADD, two were for hypertension and one was for the always-popular hypergonadism.
I know a lot of people shuffle on and off of 40-man rosters, but figure at any given time you 1,200 men on those rosters. One hundred sixteen guys represents 9.6% of players being allowed to take ADD drugs despite them otherwise being banned stimulants. For what it’s worth, the National Resource Center on ADHD and the Attention Deficit Disorder Association report that approximately 7% of children and 5% of adults have ADD or ADHD.
I have no idea whether athletic men in their 20s and 30s skew higher in this regard, and I make no assumptions about it one way or the other. Just offering that information.
Ryan Divish of the Seattle Times reports that Mariners starter Drew Smyly has a torn UCL and will undergo Tommy John surgery.
Smyly was diagnosed with a flexor strain in his left elbow at the end of spring training. He had been on the shelf since then, but was throwing bullpen sessions. He was set to throw his first simulated game today, but that was scratched after he said his arm didn’t feel right in his last throwing session. The Mariners called it “a little setback.” A reexamination shows that this is not little, obviously.
The Mariners acquired Smyly in January for outfielder Mallex Smith and two minor leaguers, and were expected to utilize the lefty as a core member of their rotation in 2017. Now he’s going to miss all of this season and, given that he’s on a one-year deal, will be released by the team at the end of the season. Odds are that he’ll be unable to pitch for most of 2018.
A play in three acts:
Miguel Montero talks smack about his teammate
A team leader talks smack about Miguel Montero
The Cubs get rid of Miguel Montero:
This is rather surprising. As I said in the last post, I figured he’d apologize today and it’d all be in the past. Guess not. Even more surprising: we learned earlier this week that the key to good clubhouse chemistry is having a teammate everyone hates. Guess that only works for the Giants.
Montero is making $14 million this season, so the Cubs are definitely eating some money to make a headache go away. They’re also losing some offensive production, as Montero has hit a nice .286/.366/.439 on the season. His terrible defense against opposing baserunners mitigates that, of course. And the whole “pissing off everyone in the clubhouse” thing isn’t exactly working out for him either, so here we are.
Oh well, have a good one, Miguel.